Fluorouracil (INN)
Fluorouracil (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

5-Fluorouracil
5-fluorouracil is a nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth. It has a role as a radiosensitizing agent, an antimetabolite, an antineoplastic agent, a xenobiotic, an immunosuppressive agent and an environmental contaminant. It is an organofluorine compound and a nucleobase analogue. It is functionally related to a uracil. — ChEBI
- IUPAC name
- 5-fluoro-1H-pyrimidine-2,4-dione
- Molecular formula
- C4H3FN2O2
- Molecular weight
- 130.08 g/mol
- Exact mass
- 130.01785550 Da
- XLogP3
- -0.9
- Topological polar surface area
- 58.2 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 3
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Fluorouracil (INN)
Chemical / IUPAC name
2,4(1H,3H)-Pyrimidinedione, 5-fluoro-
Regulatory information
Key data
Related records for Fluorouracil (INN)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Hydrofluoric acid, its normal salts, its complexes and hydrofluorides with exception of those given…
Furfuryltrimethyl ammonium salts, e.g. furtrethonium iodide (INN)
1,2,3,4,5,6-Hexachlorocyclohexane (BHC-ISO)
(1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonapht…
What Annex II means for Fluorouracil (INN)
Fluorouracil (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Fluorouracil (INN)
This page summarizes one Annex II record for Fluorouracil (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Fluorouracil (INN), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Fluorouracil (INN) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Fluorouracil (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II